StreetAlpha.app
Home › Stocks › ASH

Ashland Inc. (ASH)

Basic Materials
$74.07
▼ −2.00%
LAST CLOSE · NOV 17

Ashland makes specialty additives and ingredients for pharmaceutical, food, personal care, coatings and construction customers. It last closed at $74.07 on Nov 17, down 2.00% on the day. ASH reports earnings on Mon, Feb 1, 2027. The average 12-month price target from 3 analysts is $80.67 (+8.9% from the last close), with a high of $82.00 and a low of $80.00. Analyst consensus is Buy, based on the latest ratings from 3 firms (2 buy, 1 hold, 0 sell).

AI Auto Pilots
Is ASH in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$1.8B
−1.4% vs a year ago
Net income
$52.0M
2.8% margin
EPS (diluted)
$1.05
Gross margin
31.5%
$581.0M gross profit
Valuation
Market cap
$3.4B
45.8M shares
P/E
70.5
Price over 12 month EPS
Price to sales
1.8
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$440.0M
At Jun 30
Debt
$1.4B
At Jun 30
Shareholder equity
$1.9B
Shares outstanding
45.8M
At Jun 30
Fiscal year endsSeptember
ExchangeNYSE
Financials history
FY2021: $2.1B$2.1BFY2021FY2022: $2.4B$2.4BFY2022FY2023: $2.2B$2.2BFY2023FY2024: $2.1B$2.1BFY2024FY2025: $1.8B$1.8BFY2025

From ASH's SEC filings, latest 10-Q for the period ending Jun 30, 2026 (filed Jul 29). Last 12 months adds up the four latest quarters.

Next report
Feb 1
2027 · Time not announced
Consensus EPS forecast
$0.38
$406.0M revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Buy
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Buy
3firms
2 Buy1 Hold0 Sell
Each firm's latest rating on ASH in the past 90 days
Average 12-month target
$80.67
▲ 8.9% upside

Based on 3 analysts who set a price target on ASH in the past 90 days. The average target is $80.67, with a high of $82.00 and a low of $80.00, compared with the last close of $74.07.

Low $80.00Avg $80.67High $82.00
Blue marker: last close $74.07
Highest target$82.00
Average target$80.67
Lowest target$80.00
Latest rating changes
Wells FargoTarget raised
Nov 9Hold$70 → $80
JP MorganTarget raised
Nov 5Buy$75 → $82
UBSTarget lowered
Oct 5Buy$83 → $80
Morgan StanleyMaintained
Aug 6Hold$78
Wells FargoMaintained
Jul 31Hold$70
DateFirmActionRatingPrice target
Nov 9Wells FargoTarget raisedHold$70 → $80
Nov 5JP MorganTarget raisedBuy$75 → $82
Oct 5UBSTarget loweredBuy$83 → $80
Aug 6Morgan StanleyMaintainedHold$78
Jul 31Wells FargoMaintainedHold$70
Loading…

Technical Analysis

ASH · as of the Nov 17 close · updated after every close
Uptrend

The stock sits between its 20 and 50 day averages. It is 13% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 49). The nearest support is the Pivot S1 at $73.43, and the nearest resistance the Pivot at $74.38.

Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 2.6%/day
Key levels
$78.7552 week high+6.3%
$75.01Pivot R1+1.3%
$74.92Swing high (Aug 19)+1.1%
$74.7520 day average+0.9%
$74.38Pivot+0.4%
$74.07Last close
$73.43Pivot S1−0.9%
$72.82Swing low (Nov 3)−1.7%
$71.9650 day average−2.8%
$71.33100 day average−3.7%
$64.54200 day average−12.9%
$48.0052 week low−35.2%
Indicators
RSI (14)49.48Middle of its rangeNeutral
MACD1.09Below its signal lineBearish
Stochastic46.3Middle of its rangeNeutral
ADX (14)26.6Trending down
Williams %R-78.9Oversold below −80, overbought above −20Neutral
CCI (20)-16.2Oversold below −100, overbought above 100Neutral
Rate of change+1.3%Change over 10 sessionsBullish
ATR (14)$1.96Typical daily range, 2.6% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for ASH

What happened before

See how ASH did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow ASH usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How ASH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in ASH in the last 90 days.

Loading…

See today’s whale options flow across the market →

ASH Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲178 buying vs 150 selling
  • ●Held by funds -0.1 pts
  • ▲Funds holding +22
  • ▲Superinvestors: 4 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding378356+6.2%
In funds' top 10660.0%
Held by funds114.3%114.4%−0.1 pts
New / increased63 / 11563 / 104+6.6%
Reduced / sold out113 / 37122 / 57−16.2%
Put/call ratio0.060.14−55.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ASH institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ASH is in one of them and how their past ASH trades turned out.

ASH in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ASH in an article yet. Here's the latest on the wider market.

About Ashland

Ashland makes additives and specialty ingredients for consumer and industrial customers, including drug makers, food and beverage producers, personal care brands, paint manufacturers and construction firms. Its products include pharmaceutical excipients, nutrition ingredients, natural ingredients for skin, hair and oral care, rheology additives for coatings and construction materials, and chemical intermediates used in engineering polymers and polyurethanes. The company is headquartered in Wilmington, Delaware.

Headquarters
Wilmington, DE
Founded
1924